In a decisive move to combat the world's largest HIV epidemic, South Africa has officially launched the rollout of lenacapavir, a groundbreaking twice-yearly injectable drug designed for HIV prevention.
The rollout was unveiled by President Cyril Ramaphosa in Secunda, Mpumalanga. During the launch, President Ramaphosa characterized the long-acting treatment as a milestone in the nation's enduring struggle against HIV/AIDS, signaling a new era in public health strategy.
"This incredible treatment is not just a medicine or a drug; to us, it represents a major turning point in South Africa’s national story," President Ramaphosa stated, emphasizing the emotional and social weight of the medical advancement.
The introduction of lenacapavir is viewed as one of the most significant scientific breakthroughs since the initial advent of antiretroviral treatment. For decades, South Africa has managed an immense healthcare burden, requiring millions of people to adhere to daily medication regimes and necessitating the investment of billions of rands to sustain life and health across the population.
By shifting from daily pills to a twice-yearly injection, health officials hope to significantly increase adherence and curb the rate of new infections, providing a more sustainable and accessible path toward managing the epidemic.
Reference(s):
cgtn.com
